1. Home
  2. CYCU vs VVOS Comparison

CYCU vs VVOS Comparison

Compare CYCU & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cycurion Inc.

CYCU

Cycurion Inc.

HOLD

Current Price

$3.45

Market Cap

17.8M

Sector

N/A

ML Signal

HOLD

Logo Vivos Therapeutics Inc.

VVOS

Vivos Therapeutics Inc.

HOLD

Current Price

$2.08

Market Cap

19.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYCU
VVOS
Founded
2017
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.8M
19.4M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
CYCU
VVOS
Price
$3.45
$2.08
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$6.25
AVG Volume (30 Days)
2.0M
123.1K
Earning Date
11-14-2025
11-19-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$15,667,874.00
$17,317,000.00
Revenue This Year
N/A
$17.96
Revenue Next Year
N/A
$55.64
P/E Ratio
N/A
N/A
Revenue Growth
N/A
18.76
52 Week Low
$2.15
$1.98
52 Week High
$2,045.10
$7.95

Technical Indicators

Market Signals
Indicator
CYCU
VVOS
Relative Strength Index (RSI) 48.28 36.21
Support Level $3.15 $1.98
Resistance Level $4.40 $2.28
Average True Range (ATR) 0.42 0.13
MACD -0.15 0.02
Stochastic Oscillator 16.79 11.43

Price Performance

Historical Comparison
CYCU
VVOS

About CYCU Cycurion Inc.

Cycurion Inc. provides information technology security solutions through its subsidiaries. The Company continually strives to deliver top-notch services in risk management, cybersecurity, information assurance, systems engineering, and help desk solutions. The company generates the majority of its revenue from Advisory Consulting services, with small portion revenue generated from Managed Security Service Practice (MSSP) and Software as a Service (Saas).

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

Share on Social Networks: